Top Banner
The management of patients with CBD stone and gallstone D. Chung
36
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: The management of patients with CBD stone and gallstone D. Chung.

The management of patients with CBD stone and gallstone

D. Chung

Page 2: The management of patients with CBD stone and gallstone D. Chung.

Introduction CBD stone present in 4-10% of those presenting w

ith indication for lap cholecystectomy In era of open cholecystectomy, there was routine

use of IOC +/- exploration (1 stage) With introduction of lap chole, there was move aw

ay from IOC and surgical management of CBD to 2 stage procedure with preop or postop ERCP

Page 3: The management of patients with CBD stone and gallstone D. Chung.

Introduction Reason: Lack of expertise for LECBD and

reluctance to convert to open But, pre-op ERCP carries a significant false-

positive rate Today, the advance of lap ECBD is increasingly

reported to return the management of CBD stones to a one stage surgical procedure

Page 4: The management of patients with CBD stone and gallstone D. Chung.

Introduction Patient presented with CBD stone and gallstone

Pre op ERCP + LC (2 stage approach) LC + IOC +/- LECBD (1 stage approach)

Page 5: The management of patients with CBD stone and gallstone D. Chung.

Introduction

Two-staged approach ERCP & Laparoscopic cholecystectomy

Heinennan PM et al, Ann Surg 1989 Wilson P et al, Lancet 1991 Surick B et al, Surg Endosc 1993 Mayer C et al, J Hepato Pancreat Surg 2002 Chan CM et al, ANZ J Surg 2005

Page 6: The management of patients with CBD stone and gallstone D. Chung.

Introduction

One-staged approach Laparoscopic cholecystectomy + laparoscopic e

xploration of common bile duct

Rhodes M et al, Lancet 1998

Cuschieri A et al, Semin Laparosc Surg 2000

Lezoche E et al, Semin Laparosc Surg 2000

Nathanson LK et al, Ann Surg 2005

Paganini AM et al, Surg Endosc 2007

Page 7: The management of patients with CBD stone and gallstone D. Chung.

2 stage procedure (ERCP + lap cholecystectomy)

Page 8: The management of patients with CBD stone and gallstone D. Chung.

2 stage procedure

Methods Pre-op ERCP + lap chole Lap chole + post op ERCP

Page 9: The management of patients with CBD stone and gallstone D. Chung.

2 stage procedure

Advantage Avoid the need of T-tube Avoid the need of choledochotomy Avoid the complications of ECBD Need not to have expertise/operation set-up on

LECBD

Page 10: The management of patients with CBD stone and gallstone D. Chung.

1 stage procedure (Lap cholecystectomy + IOC +/- LECBD)

Page 11: The management of patients with CBD stone and gallstone D. Chung.

1 stage procedure

Two methods for LECBD 1) Transcystic duct exploration

Preferred method for small CBD stones and small calibre CBD

2) Choledochotomy Multiple (>3), Large CBD stone (>1 cm ) Failed transcystic duct treatment CBD > or = 9 mm on cholangiogram

Page 12: The management of patients with CBD stone and gallstone D. Chung.

1 stage procedure

Methods for closure of choledochotomy T-T closure Primary closure with stent Primary closure without stent

Page 13: The management of patients with CBD stone and gallstone D. Chung.

1 stage procedure

Factors affecting the result of LECBD Approach to LECBD (Trans-cystic vs choledoc

hotomy) Method for closure of choledochotomy Morbidity

Bile leakage

Page 14: The management of patients with CBD stone and gallstone D. Chung.

1 stage procedure Advantage

1 stage procedure/1 admission Less costly Shorter hospital stay (with transcystic duct exploration) Avoid complications of ERCP Fail ERCP Preserve biliary sphincter Avoidance of risk of further stone migration from gallb

ladder to CBD while awaiting for lap chole

Page 15: The management of patients with CBD stone and gallstone D. Chung.

Evidence?

Page 16: The management of patients with CBD stone and gallstone D. Chung.

Evidence (Case series) Case series for LECBD (Most are transcystic duct explo

ration) 300 patients, 90% ductal clearance

Martin IJ et al, Ann Surg 1998 129 consecutive patients, 92% ductal clearance

Rhodes M et al, Br J Surg 1995 268 consecutive patients, 94.3% ductal clearance

Pahanini AM et al, Ann Ital Chir 2000

Page 17: The management of patients with CBD stone and gallstone D. Chung.

Evidence (Randomised trial) Two stage approach VS LECBD (transcysti

c exploration or choledochotomy)1) Rhodes M et al, Lancet 1998 (40 cases/arm)(LC + post op ERCP VS LECBD )2) Cuschieri A et al, Surg Endos 1999 (150 cases/arm)(Pre op ERCP + LC VS LECBD, multicenter trial )

Conclusion: Same ductal clearance rate, shorter hospital stay in LECBD group

Page 18: The management of patients with CBD stone and gallstone D. Chung.

Evidence (Randomised trial) Post op ERCP VS LECBD (Choledochotom

y) Nathanson LK et al, Ann Surg 2005

372 cases of CBD stones, with 86 cases (23%) of failed transcystic duct exploration recruited to trial

Choledochotomy 41 VS ERCP clearance 45 No difference in operative time, retained stone r

ate, overall morbidity and mortality

Page 19: The management of patients with CBD stone and gallstone D. Chung.

Evidence (Randomised trial) Management of CBD stones, laparoscopic v

ersus endoscopic approach, a comparative study (pre-op ERCP + LC Vs LC + IOC +/- LECBD)

Elbatanouny, A, Zeineldin, A British Journal of Surgery, Volume 93, September 2006

No significant difference in the clearance rate between 2 management options

High rate of unnecessary ERCP in pre-op ERCP group (51.5%)

Page 20: The management of patients with CBD stone and gallstone D. Chung.

Evidence (meta-analysis)

Meta-analysis of endoscopy and surgery versus surgery alone for CBD stone with the gallbladder in situ

Clayton, E. S., Connor, S British Journal of Surgery Volume 93(10), October 2006

Page 21: The management of patients with CBD stone and gallstone D. Chung.

Evidence (meta-analysis) They identified 12 studies on Medline and ISI

databases that met the inclusion criteria for data extraction (using keywords)

Inclusion and exclusion criteria RCT in English language up to the end of March 2006 Review articles, retrospective analysis and abstracts

were not included

Page 22: The management of patients with CBD stone and gallstone D. Chung.

Table 1

                                                                                                                                                                                                                

          

Page 23: The management of patients with CBD stone and gallstone D. Chung.

Evidence (results)

Outcomes of 1357 patients were studied Successful duct clearance

77.6% in endoscopy + surgery group 79.8% lap CBD surgery group p=0.870 (n.s)

Mortality 0.9% endoscopy + surgery group 0.5% lap CBD surgery group p=0.720 (n.s)

Page 24: The management of patients with CBD stone and gallstone D. Chung.

Evidence (results) Total morbidity rate

13.6% in endoscopy + surgery group 17.1% in lap CBD surgery group p=0.710 (n.s)

Need of additional procedures after initial intervention

10.2% in endoscopy + surgery group 9.5% in lap CBD surgery group p=0.90 (n.s)

Page 25: The management of patients with CBD stone and gallstone D. Chung.

Evidence (results) No significant difference of successful duct cleara

nce, mortality, total morbidity, major morbidity, need for additional procedures between the endoscopic and surgical groups

Page 26: The management of patients with CBD stone and gallstone D. Chung.

Primary closure Vs T-tube RCT on Primary Closure vs T-Tube Closure

after choledochotomy Ha & Li et al, IHBPA 2004

Page 27: The management of patients with CBD stone and gallstone D. Chung.

Evidence (Primary closure Vs T-tube)

Primary closure of the CBD is feasible and as safe as T tube insertion after laparoscopic choledochotomy for stone disease Similar morbidity, no mortality 1 bile leak(6.6%) in primary closure group and no bile l

eak in t-tube group Similar operative time ( 108.4 Vs 116.8 minutes, p=0.5

2) Shorter postoperative hospital stay (4 Vs 8 days, p<0.0

01)

Page 28: The management of patients with CBD stone and gallstone D. Chung.

Evidence

No consensus to whether which approach is better Similar ductal clearance rate Similar morbidity and mortality

Page 29: The management of patients with CBD stone and gallstone D. Chung.

UCH experience for LECBD

Page 30: The management of patients with CBD stone and gallstone D. Chung.

UCH experience 2005-2006 Case number for LECBD

25 Age

Mean 70.3 (47-87) Operation time

Mean 212 mins (145-295) Stone clearance rate

96% (1 case with residual CBD stones)

Page 31: The management of patients with CBD stone and gallstone D. Chung.

UCH experience 2005-2006 Average CBD diameter (cm)

Mean 1.4 (1-2.5) Number of CBD stones

1-12 Conversion rate

0% All performing choledochotomy Closure of choledochotomy

23 with placement of T-tube 2 with transcystic duct drain

Page 32: The management of patients with CBD stone and gallstone D. Chung.

UCH experience 2005-2006 Hospital stay

Mean= 12.8 days (9-17) Morbidity

1 case of retained stone 1/25 (4%) 1 case with distal CBD stricture 1/25 (4%) 1 case with retained transcystic duct drain require lapar

otomy and ERCP 1/25 (4%) Mortality

0%

Page 33: The management of patients with CBD stone and gallstone D. Chung.

UCH experience 2005-2006 Follow-up period

5-20 months

Page 34: The management of patients with CBD stone and gallstone D. Chung.

Conclusion

Both 1 stage or 2 stage approaches have similar outcomes, and treatment should be determined by local resources and expertise

Page 35: The management of patients with CBD stone and gallstone D. Chung.

Our practice for LECBD

LC + LECBD (1 stage approach) Good surgical risk CBD > 1cm 1 or more stones

Especially case with large and multiple stones Fail ERCP

Page 36: The management of patients with CBD stone and gallstone D. Chung.

End